Angiotensin receptor (AT2R) agonist C21 prevents cognitive decline after permanent stroke in aged animals—A randomized double- blind pre-clinical study

Heba A. Ahmed, Tauheed Ishrat, Bindu Pillai, Kristopher M. Bunting, Almira Vazdarjanova, Jennifer L. Waller, Adviye Ergul, Susan C. Fagan

Research output: Contribution to journalArticle

Abstract

Post stroke cognitive impairment (PSCI) is an understudied, long-term complication of stroke, impacting nearly 30–40% of all stroke survivors. No cure is available once the cognitive deterioration manifests. To our knowledge, this is the first study to investigate the long-term effects of C21 treatment on the development of PSCI in aged animals. Treatments with C21 or vehicle were administered orally, 24 h post-stroke, and continued for 30 days. Outcome measures for sensorimotor and cognitive function were performed using a sequence of tests, all blindly conducted and assessed at baseline as well as at different time points post-stroke. Our findings demonstrate that the angiotensin receptor (AT2R) agonist C21 effectively prevents the development of PSCI in aged animals.

Original languageEnglish (US)
Pages (from-to)560-569
Number of pages10
JournalBehavioural Brain Research
Volume359
DOIs
StatePublished - Feb 1 2019

Fingerprint

Angiotensin Receptors
Stroke
Clinical Studies
Cognitive Dysfunction
Cognition
Outcome Assessment (Health Care)

All Science Journal Classification (ASJC) codes

  • Behavioral Neuroscience

Cite this

Angiotensin receptor (AT2R) agonist C21 prevents cognitive decline after permanent stroke in aged animals—A randomized double- blind pre-clinical study. / Ahmed, Heba A.; Ishrat, Tauheed; Pillai, Bindu; Bunting, Kristopher M.; Vazdarjanova, Almira; Waller, Jennifer L.; Ergul, Adviye; Fagan, Susan C.

In: Behavioural Brain Research, Vol. 359, 01.02.2019, p. 560-569.

Research output: Contribution to journalArticle

Ahmed, Heba A. ; Ishrat, Tauheed ; Pillai, Bindu ; Bunting, Kristopher M. ; Vazdarjanova, Almira ; Waller, Jennifer L. ; Ergul, Adviye ; Fagan, Susan C. / Angiotensin receptor (AT2R) agonist C21 prevents cognitive decline after permanent stroke in aged animals—A randomized double- blind pre-clinical study. In: Behavioural Brain Research. 2019 ; Vol. 359. pp. 560-569.
@article{db80195a980342d891d744299d64b0b7,
title = "Angiotensin receptor (AT2R) agonist C21 prevents cognitive decline after permanent stroke in aged animals—A randomized double- blind pre-clinical study",
abstract = "Post stroke cognitive impairment (PSCI) is an understudied, long-term complication of stroke, impacting nearly 30–40{\%} of all stroke survivors. No cure is available once the cognitive deterioration manifests. To our knowledge, this is the first study to investigate the long-term effects of C21 treatment on the development of PSCI in aged animals. Treatments with C21 or vehicle were administered orally, 24 h post-stroke, and continued for 30 days. Outcome measures for sensorimotor and cognitive function were performed using a sequence of tests, all blindly conducted and assessed at baseline as well as at different time points post-stroke. Our findings demonstrate that the angiotensin receptor (AT2R) agonist C21 effectively prevents the development of PSCI in aged animals.",
author = "Ahmed, {Heba A.} and Tauheed Ishrat and Bindu Pillai and Bunting, {Kristopher M.} and Almira Vazdarjanova and Waller, {Jennifer L.} and Adviye Ergul and Fagan, {Susan C.}",
year = "2019",
month = "2",
day = "1",
doi = "10.1016/j.bbr.2018.10.010",
language = "English (US)",
volume = "359",
pages = "560--569",
journal = "Behavioural Brain Research",
issn = "0166-4328",
publisher = "Elsevier",

}

TY - JOUR

T1 - Angiotensin receptor (AT2R) agonist C21 prevents cognitive decline after permanent stroke in aged animals—A randomized double- blind pre-clinical study

AU - Ahmed, Heba A.

AU - Ishrat, Tauheed

AU - Pillai, Bindu

AU - Bunting, Kristopher M.

AU - Vazdarjanova, Almira

AU - Waller, Jennifer L.

AU - Ergul, Adviye

AU - Fagan, Susan C.

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Post stroke cognitive impairment (PSCI) is an understudied, long-term complication of stroke, impacting nearly 30–40% of all stroke survivors. No cure is available once the cognitive deterioration manifests. To our knowledge, this is the first study to investigate the long-term effects of C21 treatment on the development of PSCI in aged animals. Treatments with C21 or vehicle were administered orally, 24 h post-stroke, and continued for 30 days. Outcome measures for sensorimotor and cognitive function were performed using a sequence of tests, all blindly conducted and assessed at baseline as well as at different time points post-stroke. Our findings demonstrate that the angiotensin receptor (AT2R) agonist C21 effectively prevents the development of PSCI in aged animals.

AB - Post stroke cognitive impairment (PSCI) is an understudied, long-term complication of stroke, impacting nearly 30–40% of all stroke survivors. No cure is available once the cognitive deterioration manifests. To our knowledge, this is the first study to investigate the long-term effects of C21 treatment on the development of PSCI in aged animals. Treatments with C21 or vehicle were administered orally, 24 h post-stroke, and continued for 30 days. Outcome measures for sensorimotor and cognitive function were performed using a sequence of tests, all blindly conducted and assessed at baseline as well as at different time points post-stroke. Our findings demonstrate that the angiotensin receptor (AT2R) agonist C21 effectively prevents the development of PSCI in aged animals.

UR - http://www.scopus.com/inward/record.url?scp=85055256053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055256053&partnerID=8YFLogxK

U2 - 10.1016/j.bbr.2018.10.010

DO - 10.1016/j.bbr.2018.10.010

M3 - Article

VL - 359

SP - 560

EP - 569

JO - Behavioural Brain Research

JF - Behavioural Brain Research

SN - 0166-4328

ER -